More positive trials in ALS treatment

Phase 2 US trials of a single dose of Nurown stem cell treatment from Israel’s Brainstorm on 48 patients suffering from ALS (Lou Gehrig’s disease) showed over 90% efficacy with no adverse effects. Multi-dosage trials can now take place.

(see results of Israeli trials here)

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *